C

Co-Diagnostics
D

CODX

0.24700
USD
-0.00
(-1.20%)
مغلق
حجم التداول
7,305
الربح لكل سهم
-1
العائد الربحي
-
P/E
-0
حجم السوق
8,326,995
أصول ذات صلة
A
AEMD
-0.01500
(-1.25%)
1.18500 USD
B
BNGO
-0.02000
(-0.59%)
3.37000 USD
I
IBIO
-0.01510
(-1.82%)
0.81500 USD
I
INO
-0.02500
(-1.80%)
1.36500 USD
L
LAKE
0.002
(0.01%)
14.300 USD
MRNA
MRNA
-0.650
(-1.90%)
33.630 USD
N
NVAX
-0.25000
(-3.53%)
6.84000 USD
O
OPK
0.00200
(0.15%)
1.35200 USD
V
VIR
-0.28000
(-4.72%)
5.65000 USD
المزيد
الأخبار المقالات

العنوان: Co/Diagnostics

القطاع: Healthcare
الصناعة: Medical Devices
Co-Diagnostics Inc is a molecular diagnostics company. It develops, licenses, and commercializes molecular technologies such as lab systems (MDx device) and manufacture and sell reagents used for tests that are designed using the detectionand/or analysis of nucleic acid molecules (DNA or RNA). CDI's low-cost system uses its tests to diagnose tuberculosis, Zika, hepatitis B and C, Malaria, dengue and HIV.The Company's technologies are utilized for tests that are designed using the detection and/or analysis of nucleic acid molecules (DNA or RNA). The Company also uses its proprietary technology to design specific tests for its Co-Dx PCR platform and to locate genetic markers for use in applications other than infectious diseases.